Fortrea Holdings (FTRE) Return on Invested Capital (2023 - 2026)
Fortrea Holdings (FTRE) posted Return on Invested Capital of 0.01% for Q1 2026, up 40.63% on a QoQ basis from 0.02% in Q4 2025, and up 2.0% year-over-year from 0.01% in Q1 2025.
Fortrea Holdings (FTRE) Return on Invested Capital (2023 - 2026) Analysis & Trends
Fortrea Holdings' Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.01% for Q1 2026.
- Quarterly Return on Invested Capital rose 2.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 2.0% YoY) and the FY2025 annual result came in at 0.22%, down 19.0% from the prior year.
- Return on Invested Capital was 0.01% for Q1 2026 at Fortrea Holdings, up from 0.02% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.01% in Q4 2023 and bottomed at 0.04% in Q1 2025.
- A 4-year average of 0.01% and a median of 0.01% in 2026 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2025 — Return on Invested Capital slipped 3 bps — and 2026, when it grew 2 bps.
- Fortrea Holdings' Return on Invested Capital stood at 0.01% in 2023, then sank by 397 bps to 0.02% in 2024, then tumbled by 64 bps to 0.02% in 2025, then soared by 41 bps to 0.01% in 2026.
- Business Quant data shows FTRE's Return on Invested Capital at 0.01% in Q1 2026, 0.02% in Q4 2025, and 0.03% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - | - |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - | - |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | - |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.01% |
| Sep 30, 2023 | 0.00% |